AseraCare: Falsity and the False Claims Act

Why This Topic Matters

The decision is important because it helps readers understand how courts may evaluate FCA allegations when disputed claims turn on physician judgment rather than an obvious factual error. It is especially relevant for organizations involved in hospice billing, Medicare audits, or fraud-and-abuse defense.

Article Sections

1. The Medicare Hospice Benefit: Significance of Clinical Judgment

   This section introduces the Medicare hospice benefit and the general certification framework. It also discusses the role of CMS guidance and local coverage materials in the hospice setting.

2. The False Claims Act

   This section summarizes the FCA’s basic liability framework and the statutory concepts relevant to false or fraudulent claims. It also addresses the knowledge standard described in the article.

3. Allegations Against AseraCare

   This section outlines the Government’s allegations and the overall theory of the case. It describes the type of conduct and claim activity at issue.

4. District Court Proceeding

   This section covers the sampling approach, expert review, trial structure, and the district court’s rulings. It also discusses the evidentiary dispute that led to further post-trial proceedings.

5. 11th Circuit Proceeding

   This section explains the appellate court’s analysis of hospice reimbursement, falsity, and the relationship between clinical judgment and FCA liability. It also notes the remand and the court’s discussion of how evidence must be connected to specific claims.

6. Conclusion

   This section summarizes the article’s broader implications for FCA investigations involving provider judgment. It highlights the potential relevance of the decision beyond hospice claims.